These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 1847998

  • 1. mos-induced inhibition of glucocorticoid receptor function is mediated by Fos.
    Touray M, Ryan F, Saurer S, Martin F, Jaggi R.
    Oncogene; 1991 Feb; 6(2):211-7. PubMed ID: 1847998
    [Abstract] [Full Text] [Related]

  • 2. Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun.
    Touray M, Ryan F, Jaggi R, Martin F.
    Oncogene; 1991 Jul; 6(7):1227-34. PubMed ID: 1650443
    [Abstract] [Full Text] [Related]

  • 3. Oncogene mediated repression of glucocorticoid hormone response elements and glucocorticoid receptor levels.
    Jaggi R, Höck W, Ziemiecki A, Klemenz R, Friis R, Groner B.
    Cancer Res; 1989 Apr 15; 49(8 Suppl):2266s-2274s. PubMed ID: 2564809
    [Abstract] [Full Text] [Related]

  • 4. Loss of glucocorticoid-dependent growth inhibition in transformed mouse lung cells.
    Li J, Johnson TA, Hanson LA, Beer DG.
    Mol Carcinog; 1996 Aug 15; 16(4):213-20. PubMed ID: 8784464
    [Abstract] [Full Text] [Related]

  • 5. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
    Härtig E, Cato AC.
    Cell Mol Biol Res; 1994 Aug 15; 40(7-8):643-52. PubMed ID: 7787882
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1).
    Hass R, Brach M, Kharbanda S, Giese G, Traub P, Kufe D.
    J Cell Physiol; 1991 Oct 15; 149(1):125-31. PubMed ID: 1939341
    [Abstract] [Full Text] [Related]

  • 7. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D, Lavenu A, Babinet C.
    Oncogene; 1990 Oct 15; 5(10):1511-9. PubMed ID: 2123531
    [Abstract] [Full Text] [Related]

  • 8. Antisense downregulation of a mouse mammary tumor virus activated protooncogene in mouse mammary tumor cells reverses the malignant phenotype.
    Li YX, Papkoff J, Sarkar NH.
    Virology; 1999 Mar 01; 255(1):138-49. PubMed ID: 10049829
    [Abstract] [Full Text] [Related]

  • 9. Influence of the glucocorticoid receptor on c-fos inducibility in activated ras-containing mouse lung cells.
    Johnson TA, Li J, Beer DG.
    Mol Carcinog; 1996 Oct 01; 17(2):70-7. PubMed ID: 8890955
    [Abstract] [Full Text] [Related]

  • 10. Different promoter elements are required for the induced expression of c-fos and c-jun proto-oncogenes by the v-mos oncogene product.
    Schönthal A, Feramisco JR.
    New Biol; 1990 Feb 01; 2(2):143-50. PubMed ID: 2150599
    [Abstract] [Full Text] [Related]

  • 11. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ, Rhim JS, Schlegel R, Vousden KH, Colburn NH.
    Oncogene; 1998 May 28; 16(21):2711-21. PubMed ID: 9652737
    [Abstract] [Full Text] [Related]

  • 12. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
    Agadir A, Shealy YF, Hill DL, Zhang X.
    Cancer Res; 1997 Aug 15; 57(16):3444-50. PubMed ID: 9270011
    [Abstract] [Full Text] [Related]

  • 13. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells.
    Cha HJ, Park MT, Chung HY, Kim ND, Sato H, Seiki M, Kim KW.
    Oncogene; 1998 Feb 12; 16(6):771-8. PubMed ID: 9488041
    [Abstract] [Full Text] [Related]

  • 14. Impaired AP-1 dimers and NFAT complex formation in immature thymocytes during in vivo glucocorticoid-induced apoptosis.
    Wisniewska M, Pyrzynska B, Kaminska B.
    Cell Biol Int; 2004 Feb 12; 28(11):773-80. PubMed ID: 15563399
    [Abstract] [Full Text] [Related]

  • 15. The Fos and Jun/AP-1 proteins are involved in the downregulation of Fos transcription.
    Schönthal A, Büscher M, Angel P, Rahmsdorf HJ, Ponta H, Hattori K, Chiu R, Karin M, Herrlich P.
    Oncogene; 1989 May 12; 4(5):629-36. PubMed ID: 2498806
    [Abstract] [Full Text] [Related]

  • 16. Role of chromatin structure in transcriptional regulation of MMTV LTR hormone-dependent promoter.
    Richard-Foy H, Adom J, Carr K, Gouilleux F, Marsaud V, Redeuilh G, Sabbah M, Sola B.
    Rev Esp Fisiol; 1990 Mar 12; 46(1):31-7. PubMed ID: 2168572
    [Abstract] [Full Text] [Related]

  • 17. Cell-specific bifunctional role of Jun oncogene family members on glucocorticoid receptor-dependent transcription.
    Maroder M, Farina AR, Vacca A, Felli MP, Meco D, Screpanti I, Frati L, Gulino A.
    Mol Endocrinol; 1993 Apr 12; 7(4):570-84. PubMed ID: 8388998
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1.
    Ito E, Sweterlitsch LA, Tran PB, Rauscher FJ, Narayanan R.
    Oncogene; 1990 Dec 12; 5(12):1755-60. PubMed ID: 2178237
    [Abstract] [Full Text] [Related]

  • 19. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM, Providence KM, Higgins PJ.
    Cell Motil Cytoskeleton; 2001 Mar 12; 48(3):163-74. PubMed ID: 11223948
    [Abstract] [Full Text] [Related]

  • 20. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S, Yaniv M.
    New Biol; 1989 Nov 12; 1(2):181-91. PubMed ID: 2562220
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.